US ADP Employment Change Weekly 24.75K (Prev. 23.75K)
Every headline is on the live feed 20 minutes before this site.
US ADP Employment Change Weekly 24.75K (Prev. 23.75K)
Treasury Block Trades [Rolling headline, October 13th 2026]
Yemen’s Houthis spokesperson warns Saudi Arabia that any attack on Sanaa will be met with a “harsh” response in Riyadh
On the Newsquawk feed at , 20 minutes before this page.
Context
The weekly ADP pulse is a high-frequency offshoot of the long-standing monthly series, and its track record as a standalone market mover is thin: readings of this size, hovering in a low and broadly flat range, have historically told the market little beyond confirming that hiring is neither accelerating nor collapsing. The established pattern is that traders treat these weekly prints as texture ahead of the main monthly ADP and the official payrolls report, with any repricing in rate expectations reserved for the larger releases rather than the interim ones. A marginal uptick of this kind, essentially a sideways drift, sits well within the noise band the series has exhibited since its introduction. The useful read is cumulative: several consecutive weekly prints trending in one direction have, in past episodes, prefigured the tone of the monthly employment data more reliably than any single observation. The follow-ons that matter are the monthly ADP, the claims data, and the payrolls report, where a divergence between the ADP suite and the official figures has been a recurring source of two-way volatility at the front end.
Related headlines
- Citigroup Inc. (C) Q3 2026 (USD): EPS 2.85 (exp. 2.65), Revenue 23.8bln (exp. 23.72bln)35 min ago
- Fed's Goolsbee (2027 Voter) says AI is an inflation problem, inflation is still way too high, reports Semafor1 hour ago
- JPMorgan Chase & Co. (JPM) Q3 2026 (USD): EPS 5.57 (exp. 5.93), Revenue 50.2bln (exp. 51.23bln)2 hours ago
- Johnson & Johnson (JNJ) Q3 2026 (USD): Adj. EPS 2.59 (exp. 2.67), Revenue 25.4bln (exp. 25.38bln), sees FY26 Adj. EPS between 11.05-11.15 (prev. 10.96-11.11) and Revenue 101-101.4 (prev. 100.8-101.4bln)2 hours ago
- UnitedHealth Group (UNH) Q3 2026 (USD): Adj. EPS 4.69 (exp. 4.12), Revenue 112.7bln (exp. 111.31bln). Sees FY Adj. EPS "at least" 20.50 (exp. 19.80)2 hours ago
- Fed's Waller (Voter, Dovish) says the US remains the dominant country in building AI models and AI could contribute to widening GDP per capita4 hours ago
- US President Trump says Iran will never get nuclear weapons and that this war will end very soon with gas prices to go down as soon as the war ends, while he had to change the course a little bit on Iran because we couldn't let them get a nuclear weapon12 hours ago
- Fed's Hammack (2026 voter) says more restriction is needed, but keeping an open mind on pace of rate hikes14 hours ago
- US President Trump says oil will drop when war with Iran ends very soon and stated that midterm elections will have no impact on his decisions regarding Iran15 hours ago
- US President Trump says Houthis are misbehaving very badly and he spoke with Saudi Crown Prince MBS about attacks15 hours ago
- Citi (C) raises FY26 NII to 'up mid-to-high 6%' (prev. +5-6%)29 min ago
- OPEC MOMR (Oct): 2026 demand trimmed, 2027 demand modestly increased; supply forecasts modestly increased35 min ago
- Russian President Putin holds a phone call with UAE's President and discussed Middle East and diesel deal with US 52 min ago
- Goldman Sachs Group Inc. (GS) Q3 2026 (USD): EPS 17.01 (exp. 13.07), Revenue 18.7bln (exp. 16.84bln)1 hour ago
- The political official of the IRGC says US President Trump is facing internal pressure, and we cannot bear the cost of this state of neither war nor peace alone1 hour ago
- JPMorgan (JPM) sees Q4 NII at USD 25.5bln and raises FY26 NII to USD 106.2bln (exp. 105.28bln, prev. 105.5bln)1 hour ago
- Meta (META) says Meta Ray-Ban audio glasses now on sale starting at USD 349 1 hour ago
- BioNTech (BNTX) announced that the AHEAD-MERIT Phase 2/3 clinical trial did not meet its first dual primary endpoint of progression-free survival for the mRNA cancer immunotherapy candidate BNT113 plus pembrolizumab compared with pembrolizumab alone1 hour ago
- Wells Fargo (WFC) Q3 2026 (USD): EPS 1.87 (exp. 1.85), Revenue 21.9bln (exp. 22.31bln), NII 12.5bln (exp. 12.7bln)2 hours ago
- Genmab (GMAB DC) Q3 2026 (USD): Darzalex sales 4.3bln2 hours ago
The feed had this first.
Use the Platform